Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Platinum Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences
Survival Rate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2006 2021

Research Output 2005 2017

  • 308 Citations
  • 11 Scopus h-Index
  • 20 Article
  • 5 Review article
  • 2 Chapter
  • 1 Editorial

Advances in Small Cell Lung Cancer

Kalemkerian, G. P. & Schneider, B. J. Feb 1 2017 In : Hematology/Oncology Clinics of North America. 31, 1, p. 143-156 14 p.

Research output: Contribution to journalReview article

Small Cell Lung Carcinoma
Cranial Irradiation
Neuroendocrine Tumors
Chemoradiotherapy
Smoking
4 Citations

Personalized therapy of small cell lung cancer

Schneider, B. J. & Kalemkerian, G. P. Oct 1 2016 Advances in Experimental Medicine and Biology. Springer New York LLC, Vol. 890, p. 149-174 26 p. (Advances in Experimental Medicine and Biology; vol. 890)

Research output: Chapter in Book/Report/Conference proceedingChapter

Small Cell Lung Carcinoma
Neuroendocrine Carcinoma
Growth Inhibitors
Neoplastic Stem Cells
Genomic Instability

Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer

Schneider, B. J., Kalemkerian, G. P., Gadgeel, S. M., Valdivieso, M., Hackstock, D. M., Chen, W., Heilbrun, L. K., Ruckdeschel, J. C. & Wozniak, A. J. Jul 28 2016 In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Confidence Intervals
Survival Rate
Disease-Free Survival
Safety

Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent

Saxena, A., Schneider, B. J., Christos, P. J., Audibert, L. F., Cagney, J. M. & Scheff, R. J. Feb 1 2016 In : Medical Oncology. 33, 2, p. 1-9 9 p., 13

Research output: Contribution to journalArticle

Paclitaxel
Platinum
Non-Small Cell Lung Carcinoma
Nanoparticles
Albumins
21 Citations

Definitive and adjuvant radiotherapy in locally advanced non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology evidence-based clinical practice guideline

Bezjak, A., Temin, S., Franklin, G., Giaccone, G., Govindan, R., Johnson, M. L., Rimner, A., Schneider, B. J., Strawn, J. & Azzoli, C. G. Jun 20 2015 In : Journal of Clinical Oncology. 33, 18, p. 2100-2105 6 p.

Research output: Contribution to journalArticle

Adjuvant Radiotherapy
Non-Small Cell Lung Carcinoma
Medical Oncology
Radiation Oncology
Chemoradiotherapy